medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2014, Number 2

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2014; 12 (2)

Prevalence of superficial fungal infections in patients with psoriasis under treatment with anti-TNF drugs

Angulo MAG, Rodríguez SMA, María MC, Fernández RF, Arenas R

Language: Spanish
References: 13
Page: 94-98
PDF size: 183.08 Kb.


ABSTRACT

Small, randomized trials with brief follow-ups fail to establish the increased incidence of fungal infections associated with anti- TNFα drugs. While several cases of deep mycoses have been reported, there are few documented instances of superficial fungal infections.
This paper seeks to determine the prevalence of superficial fungal infections in patients with psoriasis under anti-TNFα biologic therapy in our dermatology department.


REFERENCES

  1. Fitzpatrick TB. Dermatología en Medicina General. 4ª ed., México, Interamericana, 1997:1033-1046.

  2. Arenas R. Micología médica ilustrada. 4ª edición, México, Mc Graw Hill, 2011: 222-241.

  3. Bonifaz A. Micología médica básica. 4ª edición, México, Mc Graw Hill, 1998: 58-99.

  4. Crespo-Erchiga V y Delgado Florencio V. Malassezia yeasts and pityriasis versicolor. Curr Opin Infect Dis 2006; 19: 139-147.

  5. Rapp SR, Feldman SR, Exum ML, Fleisxe Jr AB, Reboussin DM. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 1999; 41 (3 Pt 1): 401-407.

  6. Sterry W, Baker J, Boehncke WH, Bos JD, Chimenti S, Christophers E, et al. Biological therapies in the systemic management of psoriasis; International Consensus Conference. Br J Dermatol 2004; 151: 3-17.

  7. Arnold T, Sears C, Hage C. Invasive Fungal Infections in the Era of Biologics. Clin Chest Med 2009; 30: 279-286.

  8. Tsiodras S, Samonis G, Boumpas DT, Kontoyiannis DP. Fungal Infections Complicating Tumor Necrosis Factor α Blockade Therapy. Mayo Clin Proc 2008; 83(2): 181-194

  9. Ribera M, Leal L, Luelmo L. Etanercept e infecciones. Actas Dermosifiliogr 2010; 101: 70-76.

  10. Klinkhoff A. Biological agents for rheumatoid arthrits”. Drugs 2004; 64: 1267-1283.

  11. Ellerin T, Rubin RH, Weinblatt ME. Infections and anti-tumor necrosis factor alpha therapy. Arthritis Rheum 2003; 48: 3013-3022.

  12. Lee HH, Song IH, Friedrich M, Gauliard A, Detert J, Röwert J, et all. Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-alpha antagonists. Br J Dermatol 2007; 156: 486-491.

  13. Bardazzi F, Balestri R, Rech G, Antonucci A, Patrizi A. Dermatophytosis during anti-TNF-α monoclonal antibody therapy. Mycoses 2011; 54(5): e619-20. doi: 10.1111/j.1439 0507.2010.01930.x. Epub 2010 Jul 8.




2020     |     www.medigraphic.com